tradingkey.logo
搜尋

Bionano Genomics Inc

BNGO
添加自選
1.150USD
-0.040-3.36%
收盤 05/15, 16:00美東報價延遲15分鐘
13.20M總市值
虧損本益比TTM

Bionano Genomics Inc

1.150
-0.040-3.36%

關於 Bionano Genomics Inc 公司

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc簡介

公司代碼BNGO
公司名稱Bionano Genomics Inc
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)
員工數量98
證券類型Ordinary Share
年結日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92121
電話18588887600
網址https://bionano.com/
公司代碼BNGO
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)

Bionano Genomics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
業務USD
名稱
營收
佔比
Consumables
13.97M
49.00%
Software
6.41M
22.48%
Instruments
6.36M
22.32%
Services and other
1.76M
6.19%
地區USD
名稱
營收
佔比
EMEIA
14.11M
49.49%
Americas
12.18M
42.72%
Asia Pacific
2.22M
7.79%
業務
地區
業務USD
名稱
營收
佔比
Consumables
13.97M
49.00%
Software
6.41M
22.48%
Instruments
6.36M
22.32%
Services and other
1.76M
6.19%

股東統計

更新時間: 5月14日 週四
更新時間: 5月14日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.19%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
其他
85.90%
持股股東
持股股東
佔比
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.19%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
其他
85.90%
股東類型
持股股東
佔比
Hedge Fund
5.76%
Corporation
4.73%
Investment Advisor
4.02%
Individual Investor
2.92%
Investment Advisor/Hedge Fund
0.79%
Research Firm
0.29%
其他
81.48%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
109
1.17M
10.52%
+32.26K
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Lincoln Alternative Strategies LLC
525.00K
4.73%
+525.00K
--
Sep 17, 2025
GSA Capital Partners LLP
337.78K
3.05%
+337.78K
--
Dec 31, 2025
Abbe (Richard)
322.53K
2.91%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.75%
+194.66K
--
Sep 30, 2025
DRW Securities, LLC
168.45K
1.52%
+168.45K
--
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
95.70K
0.86%
+95.70K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
66.77K
0.6%
+39.93K
+148.77%
Dec 31, 2025
Carret Asset Management, LLC
44.10K
0.4%
+19.10K
+76.40%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
公告日期
除權除息日
類型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI